Hospital-Acquired SARS-CoV-2 infection among patients admitted to a university hospital

Código QR

Hospital-Acquired SARS-CoV-2 infection among patients admitted to a university hospital

Guardado en:

Detalles Bibliográficos
Autores principales:	Josni Tauffer, Thais Claudia Roma de Oliveira Konstantyner, Maria C.S. de Almeida, Eduardo Alexandrino Medeiros
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	SARS-CoV-r2 Cross infection Infection prevention and control Health care-associated infection Infectious and parasitic diseases RC109-216 Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/4384561201fe4165938ee2f4062aceb0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

¿Es aplicable el sistema de vigilancia epidemiológica de las infecciones intrahospitalarias que recomienda el CDC- americano (sistema NNIS) en un hospital chileno?
por: Febré V,Naldy, et al.
Publicado: (2001)

Can a Nasal/Oral/Ocular Spray Inactivate and Prevent SARS-CoV-2 infection? A hypothesis
por: Fuentes,Edgardo, et al.
Publicado: (2020)

Evaluation of Residual Infectivity after SARS-CoV-2 Aerosol Transmission in a Controlled Laboratory Setting
por: Luisa Zupin, et al.
Publicado: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)

EPIDEMIOLOGY ASPECTS OF HOSPITAL-ACQUIRED INFECTION MORBIDITY IN HEALTH SURGERY HOSPITALS IN PRIMORSKY REGION
por: A. V. Martynova, et al.
Publicado: (2018)

The effect of eye protection on SARS-CoV-2 transmission: a systematic review
por: Oyungerel Byambasuren, et al.
Publicado: (2021)

Assessing SARS-CoV-2 Vertical Transmission and Neonatal Complications
por: Cosmin Citu, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
por: Lea Hsu, et al.
Publicado: (2021)

Bilateral basal ganglia ischemia associated with COVID-19: a case report and review of the literature
por: Khurram Khaliq Bhinder, et al.
Publicado: (2021)

Long-Term Modeling of SARS-CoV-2 Infection of <italic toggle="yes">In Vitro</italic> Cultured Polarized Human Airway Epithelium
por: Siyuan Hao, et al.
Publicado: (2020)

Telehealth in the times of SARS-CoV-2 infection for the otolaryngologist
por: Victoria W. Huang, et al.
Publicado: (2020)

An Observational Study on Patients with Acute Limb Ischemia and SARS-CoV-2 Infection: Early and Late Results in Limb Salvage Rate
por: Sorin Barac, et al.
Publicado: (2021)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Xiaodong Tian, et al.
Publicado: (2021)

Evidence Map and Systematic Review of Disinfection Efficacy on Environmental Surfaces in Healthcare Facilities
por: Elizabeth C. Christenson, et al.
Publicado: (2021)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
por: Olivier Bylicki, et al.
Publicado: (2021)

Potential of an Eco-Sustainable Probiotic-Cleaning Formulation in Reducing Infectivity of Enveloped Viruses
por: Maria D’Accolti, et al.
Publicado: (2021)

Hyperglycemia Induced by COVID-19 with and without Present Diabetes: A Systematic Review
por: Gembong Satria Mahardhika
Publicado: (2021)

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
por: Taweewun Hunsawong, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Haijun Tang, et al.
Publicado: (2021)

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Haijun Tang, et al.
Publicado: (2021)

Survival of COVID-19 with Multimorbidity Patients
por: E. Bustos-Vázquez, et al.
Publicado: (2021)

Vertebral Algic Syndrome Treatment in Long COVID—Cases Reports
por: Andrej Džubera, et al.
Publicado: (2021)

Potential recurrence of COVID-19 in a healthcare professional: SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity
por: Ana M Correia, et al.
Publicado: (2021)

TREATMENT OF EARLY PERIPROSTHETIC INFECTION AT HIP REPLACEMENT
por: V. N. Golnik, et al.
Publicado: (2012)

Structural-Dynamics and Binding Analysis of RBD from SARS-CoV-2 Variants of Concern (VOCs) and GRP78 Receptor Revealed Basis for Higher Infectivity
por: Abbas Khan, et al.
Publicado: (2021)

Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions
por: Alaa Muayad Altaie, et al.
Publicado: (2021)

CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA IN MULTIDISCIPLINARY HOSPITAL
por: N. F. Mulyar, et al.
Publicado: (2012)

Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series
por: Clara G. Chisari, et al.
Publicado: (2021)

High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya
por: Isaac Ngere, et al.
Publicado: (2021)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: Clement J. McDonald
Publicado: (2020)

Modeling Effects of Spatial Heterogeneities and Layered Exposure Interventions on the Spread of COVID-19 across New Jersey
por: Xiang Ren, et al.
Publicado: (2021)

An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development
por: Liang Zhang, et al.
Publicado: (2021)

Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study
por: Antonio De Vita, et al.
Publicado: (2021)

Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality
por: Mohammad Muzaffar Mir, et al.
Publicado: (2021)

EVALUATION OF INFECTION PREVENTION AND CONTROL TRAINING WORKSHOPS USING KIRKPATRICK'S MODEL
por: Saba Savul, et al.
Publicado: (2021)

Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 Pandemic
por: Francesco Ferrara, et al.
Publicado: (2020)

Identification of Cellular Factors Required for SARS-CoV-2 Replication
por: Aleksandra Synowiec, et al.
Publicado: (2021)

SARS-CoV-2 Infection in One Cat and Three Dogs Living in COVID-19-Positive Households in Madrid, Spain
por: Guadalupe Miró, et al.
Publicado: (2021)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
por: Carlos del Fresno, et al.
Publicado: (2021)

Surgical infections
Publicado: (1999)